UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934
                For the quarterly period ended September 30, 2006

                       Commission File Number 033-19411-C

                            TetriDyn Solutions, Inc.
--------------------------------------------------------------------------------
        (Exact name of small business issuer as specified in its charter)

                 Nevada                                      20-5081381
-------------------------------------------       ------------------------------
     (State or other jurisdiction                         (I.R.S. Employer
   of incorporation or organization)                     Identification No.)

                  1651 Alvin Ricken Drive, Pocatello, ID 83201
--------------------------------------------------------------------------------
                    (Address of principal executive offices)

                                 (208) 232-4200
--------------------------------------------------------------------------------
                           (Issuer's telephone number)

                                       N/A
--------------------------------------------------------------------------------
              (Former name, former address and former fiscal year,
                         if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). NO [X] YES [ ]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: As of November 9, 2006, issuer had
20,009,350 outstanding shares of common stock, par value $0.001.

Transitional Small Business Disclosure Format (check one):  YES [  ] NO [X]

<PAGE>

                                TABLE OF CONTENTS

                                                                            Page

PART I - FINANCIAL INFORMATION

         Item 1.  Financial Statements.........................................3

                  Condensed Consolidated Balance Sheets (Unaudited)............3

                  Condensed Consolidated Statements of Operations
                    (Unaudited)................................................4

                  Condensed Consolidated Statements of Stockholders'
                    Equity (Unaudited).........................................5

                  Condensed Consolidated Statements of Cash Flows
                    (Unaudited)................................................6

                  Notes to Condensed Consolidated Financial Statements
                    (Unaudited)................................................7

         Item 2.  Management's Discussion and Analysis or Plan of Operation...13

         Item 3.  Controls and Procedures.....................................17

PART II - OTHER INFORMATION

         Item 1.  Legal Proceedings...........................................18

         Item 6.  Exhibits....................................................18

         Signature............................................................18

                                       2
<PAGE>
<TABLE>
<CAPTION>
                                        PART I - FINANCIAL INFORMATION

                                          ITEM 1. FINANCIAL STATEMENTS

                                     TETRIDYN SOLUTIONS INC. AND SUBSIDIARY
                                          (A Development Stage Company)
                                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                                   (Unaudited)


                                                                                        September 30,         December 31,
                                                                                            2006                 2005
-----------------------------------------------------------------------------------------------------------------------------
<S>                                                                                       <C>                   <C>
Assets
Current Assets
  Cash                                                                                    $     71,399          $    108,311
  Accounts receivable, less allowance for doubtful accounts of $0 and $8,500                         -                 2,219
  Inventory                                                                                        263                   263
-----------------------------------------------------------------------------------------------------------------------------
Total Current Assets                                                                            71,662               110,793
-----------------------------------------------------------------------------------------------------------------------------
Property and Equipment                                                                         185,589               179,000
  Less: Accumulated depreciation                                                              (153,917)             (126,493)
-----------------------------------------------------------------------------------------------------------------------------
Net Property and Equipment                                                                      31,672                52,507
-----------------------------------------------------------------------------------------------------------------------------
Total Assets                                                                              $    103,334          $    163,300
=============================================================================================================================

Liabilities and Stockholders' Equity
Current Liabilities
  Trade accounts payable                                                                  $    187,916          $     94,325
  Accounts payable to related parties                                                            5,947                 5,947
  Accrued liabilities                                                                           62,685                72,411
  Deferred revenue                                                                              17,601                15,677
  Notes payable, current portion                                                               272,986               590,359
  Notes payable to related parties, current portion                                                  -                93,001
  Capital lease obligations, current portion                                                         -                17,636
-----------------------------------------------------------------------------------------------------------------------------
Total Current Liabilities                                                                      547,135               889,356
-----------------------------------------------------------------------------------------------------------------------------
Long-Term Liabilities
  Notes payable, net of current portion                                                        289,112               246,886
  Notes payable to related parties, net of current portion                                      77,751                     -
  Series A non-voting redeemable preferred stock - no par value; no shares and
    250,000 shares authorized, respectively; no shares and 219,512 outstanding,
    respectively                                                                                     -               696,110
-----------------------------------------------------------------------------------------------------------------------------
Total Long-Term Liabilities                                                                    366,863               942,996
-----------------------------------------------------------------------------------------------------------------------------
Stockholders' Equity
  Preferred stock - $0.001 par value; 5,000,000 shares authorized; no
    shares outstanding                                                                               -                     -
  Series B convertible preferred stock - no par value; no shares and 5,000,000
    shares authorized, respestively; no shares and 291,020 shares outstanding                        -               291,350
  Common stock - $0.001 par value; 100,000,000 shares authorized; 20,009,350
    shares and 115,152,903 shares outstanding, respectively                                     20,009                15,153
  Additional paid-in capital                                                                 1,764,430               275,971
  Deficit accumulated during the development stage                                          (2,595,103)           (2,251,526)
-----------------------------------------------------------------------------------------------------------------------------
Total Stockholders' Equity                                                                    (810,664)           (1,669,052)
-----------------------------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity                                                $    103,334          $    163,300
=============================================================================================================================


                            See the accompanying notes to condensed consolidated financial statements.

                                                                3
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                             TETRIDYN SOLUTIONS INC. AND SUBSIDIARY
                                                  (A Development Stage Company)
                                         CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                                           (Unaudited)


                                                                                                       For the Period from
                                       For the Three Months Ended         For the Nine Months Ended      October 3, 2000
                                             September 30,                      September 30,          (Date of Inception)
                                    --------------------------------   -------------------------------        through
                                        2006              2005             2006              2005       September 30, 2006
-----------------------------------------------------------------------------------------------------------------------------
<S>                                   <C>               <C>              <C>              <C>                   <C>
Revenue                               $   269,503       $    12,147      $   541,324      $   171,824           $  1,367,382
Cost of Revenue                            88,011             4,871          195,020           59,235                519,356
-----------------------------------------------------------------------------------------------------------------------------
Gross Profit                              181,492             7,276          346,304          112,589                848,026
-----------------------------------------------------------------------------------------------------------------------------
Operating Expenses
  General and administrative              130,560           116,993          351,424          220,080              2,474,294
  Selling and marketing                    77,265            49,900          198,301           91,423                314,763
  Research and development                 31,182            80,098          120,660          183,256                398,195
-----------------------------------------------------------------------------------------------------------------------------
Total Operating Expenses                  239,007           246,991          670,385          494,759              3,187,252
-----------------------------------------------------------------------------------------------------------------------------
Interest Expense                           15,397            26,504           56,996           82,048                320,877
-----------------------------------------------------------------------------------------------------------------------------
Employment Grant Income                         -                 -           37,500                -                 65,000
-----------------------------------------------------------------------------------------------------------------------------

Net Loss                              $   (72,912)      $  (266,219)     $  (343,527)     $  (464,218)          $ (2,595,103)
=============================================================================================================================

Basic and Diluted Loss
  Per Common Share                    $     (0.00)      $     (0.02)     $     (0.02)     $     (0.04)
======================================================================================================

Basic and Diluted Weighted-
  Average Common Shares
  Outstanding                          20,009,350        11,798,590       18,710,649       10,931,262
======================================================================================================


                               See the accompanying notes to condensed consolidated financial statements.

                                                                  4
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                             TETRIDYN SOLUTIONS INC. AND SUBSIDIARY
                                                  (A Development Stage Company)
                                    CONDENSED CONSOLDIATED STATEMENTS OF STOCKHOLDERS' EQUITY
                                                           (Unaudited)
                         For the Period from October 3, 2000 (Date of Inception) through December 31, 2004,
                        for the Year Ended December 31, 2005 and for the Nine Months Ended September 30, 2006



                                                                                                            Deficit
                                                         Series B                                         Accumulated
                                                      Preferred Stock        Common Stock      Additional   During the    Total
                                                    -------------------- ---------------------  Paid In    Development Stockholders'
                                                      Shares    Amount     Shares     Amount    Capital      Stage       Equity
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                                  <C>      <C>         <C>         <C>      <C>         <C>          <C>
Balance, October 3, 2000
 (Date of Inception)                                        - $       -           -   $     -  $        -  $         -  $         -
Issuance for cash, July  2002,
 $0.004 per share                                           -         -   2,073,591     2,074       1,926            -        4,000
Issuance for intellectua l property, October
 2002, $0.00 per share                                      -         -      82,944        83         (83)           -            -
Issuance for cash, July  2004, $0.015 per share             -         -   8,211,422     8,211      51,189            -       59,400
Issuance for cash, Augus t through December
 2004, $1.00 per share                                 85,000    85,000           -         -           -            -       85,000
Net loss for the period  from inception                     -         -           -         -           -   (1,617,435)  (1,617,435)
-----------------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 20 04                            85,000    85,000  10,367,957    10,368      53,032   (1,617,435)  (1,469,035)
Issuance to employees an d advisors for services,
 $0.10 per share, May th rough November 2005                -         -   2,711,355     2,711     126,345            -      129,056
Issuance for cash at $1. 00 per share, and 3,250
 shares and $2,250 cash  issued to placement
 agent, June through Dec ember 2005                   189,750   184,250           -         -           -            -      184,250
Issuance to a director f or services, $1.00 per
 share, August 2005                                     2,000     2,000           -         -           -            -        2,000
Issuance for marketing a nd consulting services,
 $0.88 per share, August  through November 2005         5,765     5,100           -         -           -            -        5,100
Issuance for conversion  of notes payable to
 related parties, August  2005, $0.10 per share             -         -   2,073,591     2,074      96,594            -       98,668
Issuance for conversion  of note payable, December
 2005, $1.00 per share                                 15,000    15,000           -         -           -            -       15,000
Net loss                                                    -         -           -         -           -     (634,091)    (634,091)
-----------------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 20 05                           297,515   291,350  15,152,903    15,153     275,971   (2,251,526)  (1,669,052)
Issuance for conversion  of note payable and
 related accrued interes t, March 2006, $1.01 per
 share,                                               250,000   252,356           -         -           -            -      252,356
Issuance for cash, March  2006, $1.00 per share       161,500   161,500           -         -           -            -      161,500
Issuance for legal servi ces, March 2006, $0.67
 per share                                                495       330           -         -           -            -          330
Conversion of Series B p referred stock into common
 stock, March 2006, $0.4 8 per share                 (709,510) (705,536)  1,471,234     1,471     704,065            -            -
Issuance to employees fo r services, January 2006,
 $0.48 per share                                            -         -      91,248        91      43,914            -       44,005
Conversion of Series A r edeemable preferred stock,
 March 2006, $1.56 per s hare                               -         -     455,178       455     707,819            -      708,274
Issuance for services to  a consultant, March 2006,
 $0.05 per share                                            -         -     829,437       830      39,170            -       40,000
Issuance in acquisition  of Creative Vending Corp.,
 March 2006, $(0.00) per  share                             -         -   2,009,350     2,009      (6,509)           -       (4,500)
Net loss                                                    -         -           -         -           -     (343,577)    (343,577)
-----------------------------------------------------------------------------------------------------------------------------------
Balance, September 30, 2006                                 - $       -  20,009,350   $20,009  $1,764,430  $(2,595,103) $  (810,664)
===================================================================================================================================


                           See the accompanying notes to condensed consolidated financial statements.

                                                                 5
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
                                             TETRIDYN SOLUTIONS INC. AND SUBSIDIARY
                                                  (A Development Stage Company)
                                         CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                           (Unaudited)

                                                                                           For the Nine Months Ended
                                                                                                  September 30,
                                                                                  --------------------------------------------
                                                                                         2006                     2005
------------------------------------------------------------------------------------------------------------------------------
<S>                                                                                       <C>                      <C>
Cash Flows from Operating Activities
Net Loss                                                                                  $ (343,577)              $ (464,218)
Adjustments to reconcile net loss to net cash used in
 operating activities:
  Depreciation                                                                                27,424                   26,850
  Interest expense from accretion of Series A preferred stock                                 12,164                   45,000
  Series B preferred stock issued for services                                                   330                    9,020
  Common stock issued for services                                                            83,345                  109,058
Changes in operating assets and liabilities:
  Accounts receivable                                                                          2,219                    3,743
  Inventory                                                                                        -                    5,975
  Accounts payable and accrued liabilities                                                    81,720                    3,883
  Deferred revenue                                                                             1,924                        -
  Other                                                                                            -                    1,500
------------------------------------------------------------------------------------------------------------------------------
Net Cash Used in Operating Activities                                                       (134,451)                (259,189)
------------------------------------------------------------------------------------------------------------------------------
Cash Flows from Investing Activities
Purchase of property and equipment                                                            (6,588)                    (300)
------------------------------------------------------------------------------------------------------------------------------
Net Cash Used in Investing Activities                                                         (6,588)                    (300)
------------------------------------------------------------------------------------------------------------------------------
Cash Flows from Financing Activities
Change in bank overdraft                                                                           -                  (16,626)
Proceeds from borrowing under notes payable                                                        -                  295,000
Principal payments on notes payable                                                          (25,148)                 (26,876)
Proceeds from notes payable to related parties                                                     -                   55,462
Principal payments on notes payable to related parties                                       (15,250)                       -
Principal payments on capital lease obligations                                              (17,635)                 (16,961)
Proceeds from issuance of common stock                                                           660                   19,544
Proceeds from issuance of Series A redeemable preferred stock                                      -                        -
Proceeds from issuance of Series B preferred stock                                           161,500                  155,000
------------------------------------------------------------------------------------------------------------------------------
Net Cash Provided by Financing Activities                                                    104,127                  464,543
------------------------------------------------------------------------------------------------------------------------------
Net Increase in Cash                                                                         (36,912)                 205,054
Cash at Beginning of Period                                                                  108,311                        -
------------------------------------------------------------------------------------------------------------------------------
Cash at End of Period                                                                     $   71,399               $  205,054
==============================================================================================================================

Schedule of Noncash Investing and Financing Activities:
Common stock issued for conversion of note payable to related party                       $        -               $   98,668
Conversion of note payable into Series B preferred stock                                     252,356                        -
Conversion of Series B preferred stock into common stock                                     705,536                        -
Conversion of Series A redeemable preferred stock into
  common stock                                                                               708,274                        -
Common stock issued in exchange for liabilities of Creative
  Vending Corp.                                                                                4,500                        -
==============================================================================================================================

                        See the accompanying notes to condensed consolidated financial statements.

                                                             6
</TABLE>
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)


Note 1 - Organization and Summary of Significant Accounting Policies

Nature of Business - TetriDyn Solutions, Inc. ("TetriDyn") and its wholly-owned
subsidiary are a development stage company that develops and markets wireless
technology and proprietary software, provides software consulting services, and
resells third-party software focused in the healthcare industry.

Organization - TetriDyn Solutions, Inc. ("TetriDyn-Idaho") was organized under
the laws of the State of Idaho on October 3, 2000. On March 22, 2006,
TetriDyn-Idaho and its shareholders completed a stock exchange agreement with
Creative Vending Corp., a Florida corporation (Creative). Under the terms of the
agreement, the TetriDyn-Idaho shareholders exchanged all of the outstanding
TetriDyn-Idaho common stock for 17,170,563 shares of Creative common stock.
Creative also issued 829,437 shares to a finder for services primarily rendered
to TetriDyn-Idaho under a July 2005 agreement. Creative had 2,009,350 shares of
common stock outstanding prior to the reorganization that remained outstanding
after the transaction. The members of the board of directors of TetriDyn-Idaho
and its management became the board of directors and management of Creative.

Due to the TetriDyn-Idaho shareholders controlling TetriDyn-Idaho before and
after the completion of the agreement, TetriDyn-Idaho was considered the
accounting acquirer. The transaction was therefore recognized as a 1-to-2.07
stock split of the common stock of TetriDyn-Idaho and the reverse acquisition of
Creative by TetriDyn-Idaho. Creative did not meet the definition of a business
under Emerging Issues Task Force Issue 98-3, Determining Whether a Nonmonetary
Transaction Involves Receipt of Productive Assets or of a Business; accordingly,
the acquisition of Creative was recognized as a nonmonetary exchange whereby the
2,009,350 shares of common stock constructively issued to the Creative
shareholders were recorded at $4,500, which was the value of the liabilities
assumed. The accompanying condensed consolidated financial statements are those
of TetriDyn-Idaho for all periods prior to the reorganization and have been
restated for the effects of the stock split for all periods presented.

On June 1, 2006, Creative changed its domicile to the State of Nevada through a
merger with and into a newly-formed subsidiary, TetriDyn Solutions, Inc., a
Nevada corporation ("TetriDyn"). The reorganization of Creative into TetriDyn
was accomplished by a 1-for-1 share exchange by the shareholders. Under Nevada
law, TetriDyn's authorized capital consists of 5,000,000 shares of preferred
stock, $0.001 par value, and 100,000,000 shares of common stock, $0.001 par
value. The accompanying condensed consolidated financial statements have been
restated for all periods presented for the effects of the change in the par
value of the common stock from no-par to $0.001 per share.

Condensed Consolidated Financial Statements - The accompanying consolidated
financial statements are condensed and do not include all disclosures normally
required by generally accepted accounting principles. These condensed
consolidated financial statements should be read in conjunction with TetriDyn's
annual financial statements included in the Company's Current Report on Form 8-K
dated March 22, 2006. In particular, the Company's organization, nature of
operations, and significant accounting principles were presented in Note 1 to
the financial statements included in that report. In the opinion of management,
all adjustments necessary for a fair presentation have been included in the
accompanying condensed consolidated financial statements and consist of only
normal recurring adjustments. The results of operations presented in the
accompanying condensed consolidated financial statements for the three and nine
months ended September 30, 2006, are not necessarily indicative of the results
that may be expected for the full year ending December 31, 2006.

                                       7
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)

Principles of Consolidation - The accompanying condensed consolidated financial
statements include the accounts and transactions of TetriDyn-Idaho on a
reorganized basis as discussed above and include the accounts and transactions
of Creative, now TetriDyn, from the date of its acquisition on March 22, 2006.
Intercompany accounts and transactions have been eliminated in consolidation.
TetriDyn and its wholly-owned subsidiary, TetriDyn-Idaho, are referred to herein
as "the Company."

Business Condition - During the year ended December 31, 2005, the nine months
ended September 30, 2006, and the three months ended September 30, 2006, the
Company suffered losses of $634,091, $343,577, and $72,912, respectively. During
the year ended December 31, 2005, and the nine months ended September 30, 2006,
the Company used $300,739 and $134,451 of cash in its operating activities,
respectively. At September 30, 2006, the Company had a working capital deficit
of $475,473 and a capital deficit of $810,664. These matters raise substantial
doubt about the Company's ability to continue as a going concern. Management is
attempting to obtain debt and equity financing for use in the Company's
operations. In addition, management is trying to expand the Company's sales and
obtain profitable operations. Realization of profitable operations or proceeds
from the financing is not assured. The accompanying condensed consolidated
financial statements do not include any adjustments relating to the
recoverability and classification of asset carrying amounts or the amount and
classification of liabilities that might result should the Company be unable to
continue as a going concern.

Stock-Based Compensation - On July 19, 2004, the Company adopted the 2004 Stock
Option Plan for employees, officers, directors, and consultants of the Company.
Through December 31, 2005, the Company had granted 2,711,355 stock options under
the plan that had been exercised and had granted 91,248 stock options that were
outstanding at December 31, 2005, and that were exercised during January 2006.
As a result of the reorganization of TetriDyn-Idaho into Creative on March 22,
2006, the 2004 Stock Option Plan was terminated.

On May 15, 2006, at a special shareholders meeting, the Company's shareholders
approved the 2006 Long-Term Incentive Plan under which up to 4,000,000 shares of
common stock may be issued. The 2006 plan is to be administered either by the
board of directors or by the appropriate committee to be appointed from time to
time by such board of directors. Awards granted under the 2006 plan may be
incentive stock options ("ISOs") (as defined in the Internal Revenue Code),
appreciation rights, options that do not qualify as ISOs, or stock bonus awards
that are awarded to employees, officers, and directors who, in the opinion of
the board or the committee, have contributed or are expected to contribute
materially to the Company's success. In addition, at the discretion of the board
of directors or the committee, options or bonus stock may be granted to
individuals who are not employees, officers or directors, but contribute to the
Company's success.

Effective January 1, 2006, the Company adopted the provisions of Statement of
Financial Accounting Standards, or SFAS, No. 123R, Share-Based Payment ("SFAS
123R"), for its stock-based compensation plan. The Company previously accounted
for stock options granted under the 2004 plan under the recognition and
measurement principles of Accounting Principles Board Opinion No. 25, Accounting
for Stock Issued to Employees ("APB 25"), and related interpretations and
disclosure requirements established by SFAS No. 123, Accounting for Stock-based
Compensation ("SFAS 123") as amended by SFAS No. 148, Accounting for Stock Based
Compensation--Transition and Disclosure.

                                       8
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)

Under SFAS 123R, all employee stock-based compensation is measured at the grant
date, based on the fair value of the option or award, and is recognized as an
expense over the requisite service, which is typically through the date the
options or awards vest. The Company adopted SFAS 123R using the modified
prospective method. Under this method, for all stock-based options and awards
granted prior to January 1, 2006, that remain outstanding as of that date,
compensation cost is recognized for the unvested portion over the remaining
requisite service period, using the grant-date fair value measured under the
original provisions of SFAS 123 for pro forma and disclosure purposes.
Furthermore, compensation costs will also be recognized for any awards issued,
modified, repurchased, or cancelled after January 1, 2006.

As the result of adoption of SFAS 123R, the Company recognized $44,005 of
compensation during January 2006 relating to stock options previously granted
and that were outstanding at December 31, 2005. The Company did not issue any
stock options or awards under the 2006 plan through September 30, 2006.

Stock options granted during the nine months ended September 30, 2005, were
exercised at the date of grant, which resulted in the stock options having no
fair value at the date of grant in excess of the intrinsic value recognized in
the September 30, 2005, financial statements. Accordingly, had the Company
recognized compensation under SFAS 123 during the three and nine months ended
September 30, 2005, the pro forma effect on net loss and basic and diluted loss
per share would not have been materially different from those amounts presented
in the accompanying September 30, 2005, financial statements.

Net Loss Per Common Share - Basic loss per common share is computed by dividing
net loss by the weighted-average number of common shares outstanding. Diluted
loss per common share is computed by dividing net loss by the weighted-average
number of common shares and dilutive potential common share equivalents
outstanding. At September 30, 2005, the Company had outstanding 219,512 shares
of Series A convertible, redeemable preferred stock and 249,020 shares of Series
B convertible preferred stock that were excluded from the calculation of diluted
loss per common share as their effects would have been antidilutive. There were
no potential common share equivalents outstanding at September 30, 2006.

Reclassifications - Certain amounts in the 2005 information have been
reclassified to conform to the 2006 presentation. These reclassifications had no
impact on the Company's net loss or cash flows.

Note 2 - Note Payable to Related Party

The Company had amounts due to a shareholder for funds loaned to the Company and
for Company expenditures covered by the shareholder. The balances due to the
shareholder at September 30, 2006, and December 31, 2005, were $77,751 and
$93,001, respectively. The notes payable bear interest at 6% per annum. During
May 2006, the shareholder and the Company agreed to modify the terms of the
notes payable such that they are due on May 30, 2008.

                                       9
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)

Note 3 - Notes Payable and Revolving Credit Agreements

During 2003, the Company entered into revolving line of credit agreements with a
bank providing for short-term borrowing. At December 31, 2003, the available
lines of credit totalled $200,000 under the terms of notes that matured during
April and June 2004. The notes bore interest at the bank's prime rate plus 2%
per annum and were payable monthly. At December 2003, the Company had borrowed
$200,000 under the terms of the credit agreements. During 2004, the Company
entered into a non-revolving line of credit agreement with a bank for up to
$50,000 and a revolving credit agreement for up to $50,000. The new notes
payable were due during 2005 and bore interest at the bank's prime rate plus
3% per annum with payments due monthly. During 2005, the Company and the bank
restructured $50,000 of the revolving credit line into a fixed term loan and
entered into other borrowing arrangements. At December 31, 2005, the Company had
borrowed an aggregate $265,692 under the terms of these new bank credit
agreements.

To finance operations, the Company used credit cards held in the name of the
Company, and guaranteed by a shareholder and officer of the Company, to finance
operations. Aggregate amounts payable under the revolving credit card agreements
total $101,706 at September 30, 2006, with required monthly payments of $2,486
as of September 30, 2006. Interest charged on the credit cards ranges from 6% to
17% per annum.

A $30,000 note payable to an economic development entity was in default at
September 30, 2006; however, the default was subsequently corrected and that the
due date of the note was extended to December 2006.

Notes payable are summarized as follows:
<TABLE>
<CAPTION>
                                                                                             September 30,           December 31,
                                                                                                 2006                    2005
-----------------------------------------------------------------------------------------------------------------------------------
<S>                                                                                           <C>                     <C>
Note payable to third party, due in monthly payments of $17,433 through October
  2005, bearing interest at 10% per annum, secured by certain
  assets and shares of common stock, in default                                               $ 125,000               $ 125,000
Note payable to third party, due in monthly payments of $1,167 through
  September 2008, bearing interest at 6.25% per annum, secured by assets                         58,670                  58,670
Note payable to bank, bearing interest at 10.75%, due June 2008, guaranteed
  by two shareholders, secured by the shareholders' personal property                           196,773                       -
Note payable to bank, bearing interest at 6.25%, due May 2006, guaranteed
  by two shareholders, secured by the shareholders' personal property                                 -                 215,964
Line of credit agreements with a bank, interest at prime plus 3%                                 49,949                  49,728
Note payable to economic development entity, non-interest bearing, due in
  December 2006, unsecured                                                                       30,000                  30,000
Note payable to redevelopment agency, bearing interest at 8.0%, payable
  in monthly payments of $3,896 through December 2012, guaranteed by
  two shareholders, unsecured                                                                         -                 250,000
Revolving credit card loans payable, due on demand, interest at 6% to
  17% per annum, unsecured, guaranteed by a shareholder                                         101,706                 107,883
----------------------------------------------------------------------------------------------------------------------------------
Total Notes Payable                                                                             562,098                 837,245
Less: Current Portion                                                                           272,986                 590,359
----------------------------------------------------------------------------------------------------------------------------------
Long-Term Notes Payable                                                                         289,112                 246,886
==================================================================================================================================
</TABLE>
                                       10
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)


Note 4 - Stockholders' Equity

Through the reverse acquisition of Creative on March 22, 2006, the Company's
common stock was reverse split on a 1-for-2.07 basis. The accompanying condensed
consolidated financial statements and related notes have been restated on a
retroactive basis for all periods presented for the effects of the stock split,
including basic and diluted loss per common share and preferred stock conversion
ratios.

Series A Redeemable Preferred Stock - On September 25, 2002, the Company issued
219,512 shares of Series A redeemable preferred stock (the Series A preferred
stock) for cash proceeds of $486,100, or $2.21 per share, which is net of
$13,900 of offering costs. The Company had the right at any time to
redeem all or any portion of the Series A preferred stock for the related pro
rata portion of the total value of $500,000 plus an 8% annual simple rate of
return. The holder of the Series A preferred stock was issued a put option with
a redemption price to be the greater of the pro rata portion of (i) $500,000
increased at an 8% annual simple rate of return or (ii) the then fair value of
the Series A preferred stock, determined by a qualified business appraiser, but
not in excess of $500,000 increased at a 12% annual simple rate of return.

In accordance with Statement of Financial Accounting Standard No. 150,
Accounting for Certain Financial Instruments with Characteristics of both
Liabilities and Equity, the Series A preferred stock was a conditional
obligation and was therefore classified as a liability. This liability was
classified as long-term based upon the terms that redemption could occur.

The future fair value of the Series A preferred stock at the dates the put
option could have been exercised was not determinable at the date of issuance.
The estimated fair value of the Series A preferred stock at the date of issuance
and at the end of each reporting period has been determined based on a 12%
annual simple rate of return. The increase in the fair value has been recognized
as interest expense. The estimated amount that would have been paid to the
holder of the Series A preferred stock if redemption had occurred on December
31, 2005, and March 22, 2006, was $696,110 and $708,274, respectively. The
amount of interest expense recognized from the change in the fair value of the
Series A preferred stock was $12,164 during 2006 through March 22, 2006.

On March 22, 2006, the holder of the Series A redeemable preferred stock
converted the 219,512 shares of Series A redeemable preferred stock into 455,178
shares of common stock at $1.56 per common share. Upon conversion, the
redemption rights and the put option held by the holder of the Series A
redeemable preferred stock expired.

Series B Convertible Preferred Stock - During March 2006, a $250,000 note
payable and $2,356 of related accrued interest were converted into 250,000
shares of Series B preferred stock at $1.01 per share. During March 2006, the
Company issued 495 shares of Series B preferred stock in payment of $330 of
legal services, or $0.67 per share. During February and March 2006, the Company
issued 161,500 shares of Series B preferred stock for $161,500 of cash in a
private placement offering at $1.00 per share.

                                       11
<PAGE>

                     TETRIDYN SOLUTIONS, INC. AND SUBSIDIARY
                          (A Development Stage Company)
            Notes to the Condensed Consolidated Financial Statements
                                   (Unaudited)


Under its original terms, each share of Series B preferred stock was convertible
at any time into one share of common stock, at a conversion price of $0.48 per
share.

On March 22, 2006, the holders of the Series B preferred stock converted all of
the 709,510 outstanding shares of Series B preferred stock into 1,471,234 shares
of common stock. The Series B preferred stock was carried at $705,536. The
conversion into common stock was at $0.48 per share. No beneficial conversion
option was recognized at the date of the conversion.

Common Stock - On March 22, 2006, the Company issued 829,437 shares of common
stock to a finder under a July 2005 agreement for services primarily rendered in
connection with the acquisition of TetriDyn-Idaho. Management has determined
that the value of the services rendered to TetriDyn-Idaho in connection with the
acquisition of Creative was $40,000 based on the estimated fair value of the
Company's common stock at July 2005 and has valued the issuance of the common
shares at $40,000, or $0.05 per share.

During January 2006, the Company issued 91,248 shares of common stock to
employees upon exercise of stock options, recognized as stock issued for
services. The common shares issued were valued at $44,005, or $0.48 per share.

                                       12
<PAGE>

        ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

The following discussion should be read in conjunction with our unaudited
condensed consolidated financial statements and notes to our financial
statements included elsewhere in this report. This discussion contains
forward-looking statements that involve risks and uncertainties. Actual results
could differ materially from those anticipated in these forward-looking
statements as a result of various factors discussed elsewhere in this report.

Certain information included herein contains statements that may be considered
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended, such as statements relating to our anticipated revenues, gross
margin and operating results, future performance and operations, plans for
future expansion, capital spending, sources of liquidity, and financing sources.
Such forward-looking information involves important risks and uncertainties that
could significantly affect anticipated results in the future, and accordingly,
such results may differ from those expressed in any forward-looking statements
made herein. These risks and uncertainties include those relating to our
liquidity requirements, the continued growth of the mobility software industry,
the success of our product-development, marketing, and sales activities,
vigorous competition in the software industry, dependence on existing
management, leverage and debt service (including sensitivity to fluctuations in
interest rates), domestic or global economic conditions, the inherent
uncertainty and costs of prolonged arbitration or litigation, and changes in
federal or state tax laws or the administration of such laws.

Overview

We provide software consulting services, develop wireless technology and
products, and resell third-party software focused in the healthcare industry.
Our business was founded as an Idaho corporation, TetriDyn Solutions, Inc. On
March 22, 2006, we completed a share exchange with Creative Vending Corp., then
inactive, that resulted in TetriDyn Solutions, Inc. becoming a wholly-owned
subsidiary of the Florida corporation, the legal acquirer. For accounting
purposes, the Idaho corporation was the accounting acquirer because its
management and controlling shareholders continued to manage and control the
consolidated enterprise following the exchange. In June 2006, we changed our
corporate domicile from Florida to Nevada.

The objectives of our software are to integrate technology and data and to
increase professional or worker productivity through the use of customized data
input screens and wireless technologies. We have developed and are offering on a
limited basis our AeroMD electronic medical records, or EMR, software product.
AeroMD EMR is a turnkey, healthcare industry software product that provides
medical practitioners with the ability to create, store, and access mobile
electronic medical records. AeroMD EMR provides (i) high efficiency encryption
and rapid secure wireless transmission of data, (ii) customized medical
specialization specific on-screen input forms, and (iii) integration of stored
data with third-party technologies.

In addition, we are in the process of developing new market opportunities in a
variety of different market segments that take advantage of previous research
and development efforts. We are also in the process of designing and developing
our DBFusion software product, which is intended to provide integration of data
from multiple locations and sources, as well as other products.

                                       13
<PAGE>

Accounting Policies

Our unaudited condensed consolidated financial statements are prepared in
conformity with accounting principles generally accepted in the United States of
America and require management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities at the date of the financial statements. Management's
estimates and assumptions may also affect the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates upon subsequent resolution of identified matters.

Revenue Recognition

Our AeroMD EMR software is provided as turnkey software that has been customized
for specific medical specializations. We typically install the software at the
customer's location for a fee and charge the customer a monthly license fee,
based on the number of operating workstations, under a one- or two-year usage
agreement. The customer is entitled to all systems upgrades during the one- or
two-year license. At the end of their contracts, customers may continue using
Aero MD by entering into a new license with us. We also sell installation and
post-contract telephone support service contracts on an hourly basis. We do not
provide any rights of return or warranties on our AeroMD EMR software.

Revenue from software licenses and related installation and support services is
recognized when earned and realizable, which is when persuasive evidence of an
arrangement exists, services, if requested by the customers, have been rendered
and are determinable, and collectibility is reasonably assured. Amounts billed
to customers prior to these criteria being met are deferred. Revenue from the
sale of software is recognized when delivered to the customer or upon
installation of the software if an installation contract exists. Revenue from
post-contract telephone support service contracts is recognized as the services
are provided, determined on an hourly basis. Revenue applicable to
multiple-element fee arrangements is divided among the software, the
installation, and post-contract support service contracts using vendor-specific
objective evidence of fair value. Fair value is evidenced by the prices charged
when the software and the services are sold as separate products or
arrangements.

We also provide information technology management consulting services. To date,
these services have been primarily in the hospital industry. These services are
paid for on a monthly basis and for a flat-fee, which is not cancelable or
refundable. Revenue for these services is recognized in the month in which it is
received.

Description of Expenses

General and administrative expenses consist primarily of professional fees,
salaries, and related costs for accounting, administration, finance, human
resources, information systems, and legal personnel.

Selling and marketing expenses consist primarily of advertising, promotional
activities, trade shows, travel, and personnel-related expenses.

Research and development expenses consist of payroll and related costs for
software engineers, management personnel, and the costs of materials used by
these employees in the development of new or enhanced product offerings.

                                       14
<PAGE>

In accordance with Financial Accounting Standards Board SFAS No. 86, Accounting
for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed,
development costs incurred in the research and development of new software
products to be sold, leased, or otherwise marketed are expensed as incurred
until technological feasibility in the form of a working model has been
established. Internally-generated capitalizable software development costs have
not been material to date. We have charged our software development cost to
research and development expense in our statements of operations.

Property and equipment are recorded at cost. Maintenance, repairs, and renewals
that neither materially add to the value of the property nor appreciably prolong
its life are charged to expense as incurred. Property and equipment are
depreciated using the straight-line method over the estimated useful lives of
the assets. Gains or losses on dispositions of property and equipment are
included in the results of operations when realized.

Results of Operations

     Comparison of Three and Nine Months Ended September 30, 2006 and 2005

         Revenues

Our revenue was $269,503 and $541,324 for the three and nine months ended
September 30, 2006, respectively, compared to $12,147 and $171,824 for the three
and nine months ended September 30, 2005, respectively, representing an increase
of $257,356, or 2,119%, and $369,500, or 215%, for the three- and nine-month
periods, respectively. The increase in revenues was due to a consulting services
contract with a regional hospital and increased AeroMD and third-party software
sales during the quarters ended June 30, 2006, and September 30, 2006.

         Cost of Revenue

Our cost of revenue was $88,011 and $195,020 for the three and nine months ended
September 30, 2006, respectively, compared to $4,871 and $59,235 for the three
and nine months ended September 30, 2005, respectively, representing an increase
of $83,140, or 1,707%, and $135,785, or 229%, for the three- and nine-month
periods, respectively. The gross margin percentage on revenue was 67% and 64%
for the three and nine months ended September 30, 2006, respectively, and 60%
and 66% for the three and nine months ended September 30, 2005, respectively.
The increased cost of revenue was due to the initiation of a consulting service
contract, which we performed by reassigning some personnel from administrative
and research and development functions. This reassignment increased cost of
revenue and correspondingly decreased operating costs, which also affected the
gross margin percentage in 2006.

Although the net changes and percent changes with respect to our revenues and
our cost of revenue for the three and nine months ended September 30, 2006 and
2005, are summarized above, the trends contained therein are limited and should
not be viewed as a definitive indication of our future results.

                                       15
<PAGE>

         Operating Expenses

General and Administrative -- General and administrative expenses, including
noncash compensation expense, were $130,560 and $351,424 for the three and nine
months ended September 30, 2006, respectively, compared to $116,993 and $220,080
for the three and nine months ended September 30, 2005, respectively,
representing an increase of $13,567, or 12%, and $131,344, or 60%, for the
three- and nine-month periods, respectively. The increase in our general and
administrative expenses from the three- and nine-month periods ended September
30, 2006, as compared to the three and nine months ended September 30, 2005,
reflects legal, accounting, and administration fees incurred in 2006 directly
related to the reverse acquisition of TetriDyn Solutions, Inc. by Creative
Vending Corp., the name and domicile change to Nevada, and Securities and
Exchange Commission filing requirements.

Selling and Marketing -- Selling and marketing expenses, including noncash
compensation expense, were $77,265 and $198,301 for the three and nine months
ended September 30, 2006, respectively, compared to $49,900 and $91,423 for the
three and nine months ended September 30, 2005, respectively, representing an
increase of $27,365, or 55%, and $106,878, or 117%, for the three- and
nine-month periods, respectively. The increase in our selling and marketing
expenses from the three and nine months ended September 30, 2006, as compared to
the three and nine months ended September 30, 2005, reflects our increased focus
on marketing, including increased sales staff, advertising, and customer
contact.

Research and Development Expenses -- Research and development expenses were
$31,182 and $120,660 for the three and nine months ended September 30, 2006,
respectively, compared to $80,098 and $183,256 for the three and nine months
ended September 30, 2005, respectively, representing a decrease of $48,916, or
61%, and $62,596, or 34%, for the three- and nine-month periods, respectively.
The decrease in research and development expenses reflects our increased focus
on consulting services contract and sales and marketing activities while
reducing our focus on research and development activities.

Interest expense was $15,397 and $56,996 for the three and nine months ended
September 30, 2006, respectively, as compared to $26,504 and $82,048 for the
three and nine months ended September 30, 2005, respectively, a decrease of
$11,107, or 42%, and $25,052, or 31%, for the three- and nine-month periods,
respectively. The decrease in interest expense related primarily to our
conversion of outstanding debt to common stock in connection with the reverse
acquisition, thereby reducing our interest expense.

Liquidity and Capital Resources

At September 30, 2006, our principal sources of liquidity consisted of $71,399
of cash, as compared to $108,311 of cash at December 31, 2005. In addition, our
stockholders' deficit was $810,664 at September 30, 2006, compared to
stockholders' deficit of $1,669,052 at December 31, 2005, a decrease in the
deficit of $858,388. The reduction in the deficit reflects the conversion of
pre-acquisition Series A redeemable preferred stock to common stock and the
conversion of a $250,000 loan to common stock in connection with the reverse
acquisition completed in March 2006.

Our operations used net cash of $134,451 during the nine months ended September
30, 2006, as compared to $259,189 of net cash used during the nine months ended
September 30, 2005. The $124,738 decrease in the net cash used by our operating
activities primarily resulted from increased revenue causing our net loss to be
substantially less during the nine months ended September 30, 2006, versus the
nine months ended September 30, 2005.

                                       16
<PAGE>

Investing activities for the nine months ended September 30, 2006, used $6,588
of net cash, as compared to $300 of net cash used during the nine months ended
September 30, 2005. The increase in net cash used related primarily to the
purchase of additional computer equipment in support of the consulting services
contract personnel engaged in 2006.

Financing activities provided $104,127 during the nine months ended September
30, 2006, compared to providing net cash of $464,543 during the nine months
ended September 30, 2005. The decrease of $360,416 of net cash provided in
financing activities primarily resulted from two loans being obtained in the
three months ended September 30, 2005.

We are focusing our efforts on increasing revenue while we explore external
funding alternatives. In addition, we intend to seek compromise and resolution
of $125,000 in indebtedness due a community development agency, now in default,
principally by execution on the collateral. If we are able to resolve this
indebtedness in this manner, we currently have contracts in place for future
deliveries that we believe will cover our minimum expenditures for operating
costs and minimum installments due on our other indebtedness to non-affiliates,
excluding costs for new product development and rollout and reduction of
indebtedness over minimum installments due. However, in order for us to continue
to grow, we will be required to increase our revenues further and to seek
additional external capital. Our growth will be restricted if we are unable to
obtain external funding. On October 25, 2006, our common stock began being
quoted on the OTCBB and the Pink Sheets, which we anticipate may improve our
access to equity capital. Additionally, as we continue development of new
products and identify specific commercialization opportunities, we will focus on
those product markets and opportunities for which we might be able to get
external funding through joint venture agreements, strategic partnerships, or
other direct investments.

We have no significant contractual obligations or commercial commitments not
reflected on our balance sheet as of this date.


                         ITEM 3. CONTROLS AND PROCEDURES

We maintain disclosure controls and procedures that are designed to ensure that
information required to be disclosed by us in the reports that we file or submit
to the Securities and Exchange Commission under the Securities Exchange Act of
1934, as amended (the "Securities Exchange Act"), is recorded, processed,
summarized and reported within the time periods specified by the Securities and
Exchange Commission's rules and forms, and that information is accumulated and
communicated to our management, including our principal executive and principal
financial officers (whom we refer to in this periodic report as our Certifying
Officers), as appropriate to allow timely decisions regarding required
disclosure. Our management evaluated, with the participation of our Certifying
Officers, the effectiveness of our disclosure controls and procedures (as
defined in Rule 13a-15(e) under the Securities Exchange Act) as of September 30,
2006, pursuant to Rule 13a-15(b) under the Securities Exchange Act. Based upon
that evaluation, our Certifying Officers concluded that, as of September 30,
2006, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting that
occurred during our most recently completed fiscal quarter that have materially
affected, or are reasonably likely to materially affect, our internal control
over financial reporting.

                                       17
<PAGE>

                           PART II - OTHER INFORMATION


                            ITEM 1. LEGAL PROCEEDINGS

We are, from time to time, a party to legal proceedings arising out of our
business. We believe that there are no proceedings pending or threatened against
us which, if determined adversely, would have a material adverse effect on our
business, financial condition, and results of operations or liquidity.


                                ITEM 6. EXHIBITS

The following exhibits are filed as a part of this report:

     Exhibit
     Number*                Title of Document                         Location
-------------- ----------------------------------------------------  -----------

    Item 31    Rule 13a-14(a)/15d-14(a) Certifications
-------------- ----------------------------------------------------  -----------
     31.01     Certification of Principal Executive Officer and      Attached
               Principal Financial Officer Pursuant to Rule 13a-14

    Item 32    Section 1350 Certifications
-------------- ----------------------------------------------------  -----------
     32.01     Certification Pursuant to 18 U.S.C. Section 1350,     Attached
               as Adopted Pursuant to Section 906 of the
               Sarbanes-Oxley Act of 2002 (Chief Executive
               Officer and Chief Financial Officer)
--------------
*    All exhibits are numbered with the number preceding the decimal indicating
     the applicable SEC reference number in Item 601 and the number following
     the decimal indicating the sequence of the particular document.


                                    SIGNATURE

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                             TETRIDYN SOLUTIONS, INC.
                                                 (Registrant)

Date:  November 13, 2006                     By  /s/ David W. Hempstead
                                                 -------------------------------
                                                David W. Hempstead, President,
                                                Chief Executive Officer,
                                                and Chief Financial Officer

                                       18